Surgiphor Us in TSA
Effect of Surgiphor (sterile Povidone-Iodine) Wound Irrigation on Rate of Positive Deep Culture and NGS in Primary Total Shoulder Arthroplasty- a Prospective, Randomized Pilot Study
1 other identifier
interventional
126
1 country
1
Brief Summary
Bacteria is occasionally present in the shoulder during shoulder arthroplasty surgery and is hypothesized to increase the risk of failure of the prosthesis. Surgiphor (sterile Povidone-Iodine) wound irrigation, is a solution used in orthopaedic surgery and other surgical fields to kill bacteria intraoperatively. The Iodine dissociates from complex and has antimicrobial properties, causing cell death of bacteria, fungi, and viruses through interactions with proteins, nucleotides, and fatty acids in the cytoplasm and cytoplasmic membrane. This study examines the use of Povidone-Iodine during primary shoulder arthroplasty.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_4
Started Sep 2024
Shorter than P25 for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 16, 2024
CompletedStudy Start
First participant enrolled
September 16, 2024
CompletedFirst Posted
Study publicly available on registry
September 19, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2025
CompletedSeptember 19, 2024
September 1, 2024
1 year
September 16, 2024
September 16, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Reduction or elimination of bacteria
To determine the rate of reduction of positive cultures collected before and after wound irrigation with either Surgiphor or sterile normal saline during primary total shoulder arthroplasty participants will be followed to watch for clinical signs of infection.
90 days
Study Arms (2)
Total Shoulder Arthroplasty washed with Saline
ACTIVE COMPARATORThis arm will consist of sterile normal saline to be used before and after placement of shoulder arthroplasty components
Total Shoulder Arthroplasty washed with Surgiphor (Povidone Iodine)
ACTIVE COMPARATORThis arm will consist of Surgiphor to be used before and after placement of shoulder arthroplasty components
Interventions
The shoulder will be washed with normal sterile saline before and after placing the shoulder implant
The shoulder will be washed with Surgiphor (Povidone Iodine) before and after placing the shoulder implant
During the surgical procedure, 4 swabs of the surgical wound will be taken at various times throughout the procedure
Eligibility Criteria
You may qualify if:
- Adults age \>18 years
- Participants undergoing elective primary total shoulder arthroplasty
- Participants willing to provide written consent
You may not qualify if:
- History of prior surgery to the operative shoulder
- Known allergy to povidone iodine, iodine or shellfish
- active clinical infection
- participation in other clinical trials
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Rothman Orthopaedic Institute
Philadelphia, Pennsylvania, 19107, United States
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 16, 2024
First Posted
September 19, 2024
Study Start
September 16, 2024
Primary Completion
September 30, 2025
Study Completion
September 30, 2025
Last Updated
September 19, 2024
Record last verified: 2024-09
Data Sharing
- IPD Sharing
- Will not share